 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Carr Financial Group Corp grew its position in shares of GSK plc (NYSE:GSK  Free Report) by 3.4% in the second quarter, according to its most recent 13F filing with the Securities and Exchange...

Carr Financial Group Corp Grows Stake in GSK plc (NYSE:GSK)

Foster Victor Wealth Advisors LLC grew its holdings in shares of GSK plc (NYSE:GSK  Free Report) by 5.7% in the second quarter, according to the company in its most recent 13F filing with the...

Foster Victor Wealth Advisors LLC Acquires 7,588 Shares of GSK plc (NYSE:GSK)

GSK becomes first company to pledge to officially adopt nature risk disclosure guidance...

'Milestone': Taskforce for Nature-related Financial Disclosures publishes final recommendations

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

GSK price target raised to 1,575 GBp from 1,450 GBp at Barclays

GSK shuffles R&D as research head John Lepore heads out the door
gmasson
Mon, 09/18/2023 - 14:46...

GSK shuffles R&D as research head John Lepore heads out the door

I think a Stocks and Shares ISA is the best way for me to invest. But we can benefit from knowing a few things about them.
I dont just mean the ISA rules and regulations, which can be found...

3 things every Stocks and Shares ISA investor needs to know

Sanders Morris Harris LLC acquired a new position in shares of GSK plc (NYSE:GSK  Free Report) in the 2nd quarter, according to its most recent filing with the SEC. The fund acquired 13,360...

Sanders Morris Harris LLC Makes New $472,000 Investment in GSK plc (NYSE:GSK)

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Ojjaara (momelotinib) for the treatment of intermediate or high-risk myelofibrosis, including...

Ojjaara (momelotinib) approved in the US as the first and only treatment indicated for myelofibrosis patients with anemia

GSK says FDA approves Ojjaara for treatment of myelofibrosis

Investors in GSK plc (GSK) saw new options begin trading today, for the May 2024 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so...

May 2024 Options Now Available For GSK

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Watchers	9,231
52-Wk Low	$28.47
52-Wk High	$39.74

Market Cap	$75.85B
Volume (M)	4.46M
52-Wk High	$39.74
52-Wk Low	$28.47

GSK Glaxosmithkline plc - ADR

About

Feed

News

Sentiment

Earnings

Fundamentals